Susan Kalled - 18 Feb 2022 Form 4/A - Amendment Insider Report for Compass Therapeutics, Inc. (CMPX)

Reporting relationship
Chief Scientific Officer
Issuer ticker
CMPX
Reported as of
18 Feb 2022
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4/A - Amendment
Accepted by SEC
23 Feb 2022, 16:30:41 UTC
Original report date
18 Feb 2022
Prior SEC filing
18 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Susan Kalled

Key filing fact

Susan Kalled filed Form 4/A - Amendment for Compass Therapeutics, Inc. (CMPX) on 23 Feb 2022.

Key facts

  • This page summarizes Susan Kalled's Form 4/A - Amendment filing for Compass Therapeutics, Inc. (CMPX).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 23 Feb 2022, 16:30.

Change

  • Previous filing in this sequence was filed on 18 Feb 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CMPX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+60,000
Change %
Price
$0.000000
Shares after
60,000
Date
18 Feb 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
60,000
Exercise price
$2.40
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vest over 48 substantially equal monthly installments starting 03/17/2022.

SEC remarks

This Form 4/A is being filed to correct the transaction date and exercise price reported on the original Form 4 filed on February 18, 2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .